Brand-Generic Pay-For-Delay Deals May Become Extinct, FTC Finds

 
• By Brenda Sandburg

Only one of 232 brand-generic patent suit settlements in the US during FY 2016 contained a side deal or commitment not to market an authorized generic.  

3D rendering of Tyrannosaurus Rex near extinction. - Illustration
Will pay-for-delay deals between brand and generic companies go the way of T. Rex? • Source: Shutterstock

More from Generics

More from Biosimilars & Generics